Delivery Order SPE2DB24D1104-SPE2DB25FXVY4

Award Date 12/24/24
Potential Completion Date 12/26/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a specialty medication. The contract has a ceiling value of $2,006.16 and a period of performance through January 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a pharmaceutical product, with a ceiling value of $1,054.96 and a period of performance through January 15, 2025. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication, with a ceiling value of $1,187.75 and a period of performance through January 31, 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,568.51, is for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML medical products. The contract has an ultimate completion date of January 28, 2025 and is a Firm Fixed Price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566998409 NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication, with a ceiling value of $2,154.42 and an ultimate completion date of January 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,143.07 and is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML, a specialty medication. The contract is a firm fixed-price delivery order with a completion date of December 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Norditropin FlexPro 15 mg/1.5 ml medication, with a ceiling value of $1,456.63 and a period of performance through February 3, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NORDITROPIN FLEXPRO 5 MG/1.5 1.5ML medical products. The contract has a firm fixed price and a ceiling value of $1,550.41. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML medical supplies. The order, valued at $1,135.97, has a firm fixed price and an ultimate completion date of June 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA valued at $999,999,999, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,240.06, is for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXVY4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML. The contract has a ceiling value of $2,626.68 and a period of performance through December 26, 2024. The contract is a firm fixed price delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 3/25/25, 9:49 AM